Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESSENTIAL Trial: Esketamine and Dexmedetomidine for Hyperactive Delirium in ICU
NCT07377981Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in delirium, agitation, sponsored by Jiangsu Provincial People's Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
deliriumagitation
Beyond the preview
Go deeper on NCT07377981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07377981.